Imaging the serotonin transporter during major depressive disorder and antidepressant treatment
about
A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorderTriangulating perspectives on functional neuroimaging for disorders of mental healthThe role of serotonin in sleep disordered breathing associated with Parkinson disease: a correlative [11C]DASB PET imaging studyImaging phenotypes of major depressive disorder: genetic correlatesSerotonin transporter availability in the amygdala and bed nucleus of the stria terminalis predicts anxious temperament and brain glucose metabolic activityOscillatory serotonin function in depression.Imaging serotonergic transmission with [11C]DASB-PET in depressed and non-depressed patients infected with HIV.Prediction of repeat-dose occupancy from single-dose data: characterisation of the relationship between plasma pharmacokinetics and brain target occupancy.Exploring the impact of BDNF Val66Met genotype on serotonin transporter and serotonin-1A receptor bindingSkeletal effects of serotonin (5-hydroxytryptamine) transporter inhibition: evidence from in vitro and animal-based studiesTime series fMRI measures detect changes in pontine raphé following acute tryptophan depletionBrain serotonin transporter occupancy by oral sibutramine dosed to steady state: a PET study using (11)C-DASB in healthy humans.Familial risk for major depression is associated with lower striatal 5-HT₄ receptor bindingThe role of molecular imaging in the diagnosis and management of neuropsychiatric disorders.Serotonin and mental disorders: a concise review on molecular neuroimaging evidence123I-ADAM SPET imaging of serotonin transporter in patients with epilepsy and comorbid depression.Age and sex effects on 5-HT(4) receptors in the human brain: a [(11)C]SB207145 PET study.Ontogeny and regulation of the serotonin transporter: providing insights into human disorders.Alterations in white matter fractional anisotropy in subsyndromal perimenopausal depression.Incongruent reduction of serotonin transporter associated with suicide attempts in patients with major depressive disorder: a positron emission tomography study with 4-[18F]-ADAMLong-term ovariectomy decreases serotonin neuron number and gene expression in free ranging macaques.Serotonin transporter binding after recovery from bulimia nervosa.In vivo quantification of the [(11)C]DASB binding in the normal canine brain using positron emission tomographyIn Vivo Evaluation of Blood Based and Reference Tissue Based PET Quantifications of [11C]DASB in the Canine Brain.Disproportionate Reduction of Serotonin Transporter May Predict the Response and Adherence to Antidepressants in Patients with Major Depressive Disorder: A Positron Emission Tomography Study with 4-[18F]-ADAM.High-Dose Testosterone Treatment Increases Serotonin Transporter Binding in Transgender People.Serotonin transporter occupancy with TCAs and SSRIs: a PET study in patients with major depressive disorder.Effects of acute tryptophan depletion on raphé functional connectivity in depressionNeuroticism Associates with Cerebral in Vivo Serotonin Transporter Binding Differently in Males and Females.Multi-modality: a new approach for the treatment of major depressive disorder.Cerebral amyloid deposition and serotoninergic innervation in Parkinson disease.Positron emission tomography quantification of serotonin transporter in suicide attempters with major depressive disorderSymptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease.Synthesis, radiosynthesis, and biological evaluation of fluorine-18-labeled 2beta-carbo(fluoroalkoxy)-3beta-(3'-((Z)-2-haloethenyl)phenyl)nortropanes: candidate radioligands for in vivo imaging of the serotonin transporter with positron emission tomClinical implications of genetic variation in the serotonin transporter promoter region: a review.Genome-wide expression profiling of human lymphoblastoid cell lines implicates integrin beta-3 in the mode of action of antidepressantsInteraction between serotonin transporter and dopamine D2/D3 receptor radioligand measures is associated with harm avoidant symptoms in anorexia and bulimia nervosaGlia and immune cell signaling in bipolar disorder: insights from neuropharmacology and molecular imaging to clinical application.Gene expression-based biological test for major depressive disorder: an advanced study.Fluorine-18 Radiolabeled PET Tracers for Imaging Monoamine Transporters: Dopamine, Serotonin, and Norepinephrine.
P2860
Q24624059-75CCE0B0-0819-408C-9FA3-37FA5477E69AQ27497063-DBE4011D-E5E1-484B-B199-C26546C2B13BQ28727519-51D1C6D8-F2C5-4097-B811-2D52777626DDQ30478592-3235F4BD-A143-4E98-A27C-24590690D8C5Q30490740-B2B8D673-5BF6-4B2F-9751-9CDD412F656DQ30617531-E50F8DC8-9DB9-46F1-97F8-74BB5A2A92C7Q33637117-7FC0B36F-5ACC-4C0C-9E56-616578E61FEAQ33716001-8DA9DDC2-C01E-4256-A265-2026100467E1Q34134231-28EC46AE-5462-47C5-BA8B-6D43ED460575Q34140313-E7DE8465-4D83-4823-B445-BCD69E0F0B95Q34588901-75E1A2DD-4790-48CB-B250-B9619CA22E49Q34661571-9F468A6B-4A94-40B0-B816-26B0A619F824Q34667157-EAD9E0E1-6DFC-460B-97F9-2288AB543D98Q34897526-CAB86014-BE99-4EDE-9D64-6215AD346A47Q34942640-E822B16D-8E78-4059-88F7-5CA71BA77B8FQ35068437-AE3FE5D7-2129-466F-8990-C378370DB9D6Q35088193-EFBCDA75-726A-4796-B3E3-4F895FC8CC41Q35090255-46BC8B32-55D0-4B60-B74C-C1950407D4DBQ35165235-FD45E2C7-63CD-4BFA-844B-5AD70B721C6DQ35179035-3877FDA1-7EAC-4F68-ABA4-175EB5033485Q35194757-0B7DFDB8-3AE2-4139-8E6B-2BE52D1C5B53Q35218866-3CC9C701-95A2-44B6-A600-0777B6362E00Q35878500-AE730464-AE3F-4AF1-9F07-41C09FCCBBF7Q35918437-0D818404-5FC8-4CF3-88DE-8A10FFBA7A9CQ35965853-3D594C81-6ED9-4126-9C7B-8FD14A43B3BCQ36098853-DEF11F19-53A1-4334-ABA3-F998EB26F303Q36132042-EEA41D75-7154-446B-952A-6A40F7FD5A78Q36244660-43AA6C3B-1813-4632-B978-EDDE92F46A5CQ36457300-CA3786AA-0631-4421-BF73-362C0D4A3CC3Q36896252-557A0F08-BCA7-419F-87DF-AF3E02C4FC38Q36899059-61255203-CC43-4931-BDF5-FB324419B827Q37049887-5FC12D77-4A99-4FE7-B942-1C6A810FE9A3Q37056546-F0A88137-0845-46C3-AE1E-8F8FE50D8B1CQ37156598-CFEDEB24-F2EA-4C5F-B7C7-2EA9195AD8DBQ37255370-9B5CE171-CB0D-4364-B3B0-60DCA78EACC1Q37281179-ED40699D-2C7B-4C2F-9341-0454CA40CACFQ37430839-11C7AF01-2527-40EE-A9A7-02A2577D01E3Q37526428-078DF795-24C2-4A3F-9BB7-05B14F74F9D4Q37669886-A1ACF6E4-7E1E-4579-9BC5-217EF97570B3Q37706110-2B5B96AC-24FB-49FF-BB91-66B8E036C74D
P2860
Imaging the serotonin transporter during major depressive disorder and antidepressant treatment
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Imaging the serotonin transpor ...... r and antidepressant treatment
@ast
Imaging the serotonin transpor ...... r and antidepressant treatment
@en
Imaging the serotonin transpor ...... r and antidepressant treatment
@nl
type
label
Imaging the serotonin transpor ...... r and antidepressant treatment
@ast
Imaging the serotonin transpor ...... r and antidepressant treatment
@en
Imaging the serotonin transpor ...... r and antidepressant treatment
@nl
prefLabel
Imaging the serotonin transpor ...... r and antidepressant treatment
@ast
Imaging the serotonin transpor ...... r and antidepressant treatment
@en
Imaging the serotonin transpor ...... r and antidepressant treatment
@nl
P2860
P1476
Imaging the serotonin transpor ...... r and antidepressant treatment
@en
P2093
Jeffrey H Meyer
P2860
P304
P407
P577
2007-03-01T00:00:00Z